CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 1,316 enrolled
Drug / intervention
Fluzone® (Aventis Pasteur inactivated influenza vaccine)biological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00283283
NCT00283283Phase 2Completed
CompareCT.gov

Clinical Study to Compare the Immune Response of Half Dose Trivalent Inactivated Influenza Vaccine (TIV) to Full Dose

U.S. Army Medical Research and Development Command·interventional·Posted Jan 27, 2006·Updated Feb 12, 2021

In Brief

A Phase 2 clinical trial evaluating Fluzone® (Aventis Pasteur inactivated influenza vaccine) for Influenza. Completed, enrolled 1,316 participants across 2 sites.

Detailed Summary

This study compared full-dose Flu vaccine to half-dose Flu-vaccine during the 2004-2005 flu season.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States
CollaboratorsWalter Reed Army Medical Center, United States Army Medical Materiel Development Activity, Centers for Disease Control and Prevention, Uniformed Services University of the Health Sciences, Walter Reed Army Institute of Research (WRAIR), U.S. Air Force Office of the Surgeon General

Timeline

Phase 2CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 27, 2006
Enrollment StartNov 1, 2004
Primary CompletionNov 1, 2004
Study CompletionMay 1, 2006
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 20.4 years ago

Interventions

Fluzone® (Aventis Pasteur inactivated influenza vaccine)biological

A/H1N1, A/New Caledonia/20/99; A/H3N2, A/Fujian/411/2002; B, B/Shanghai/361/2002